Creative Medical Technology Holdings, Inc. (CELZ) Gross margin 2017–2025
Creative Medical Technology Holdings, Inc. (CELZ) gross margin by fiscal year — reported gross profit divided by reported revenue.
63.4%FY2025 · since FY2017: -66.7% → 63.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 63.4% | +3.4 pp |
| FY2024 | 60.0% | +0.0 pp |
| FY2023 | 60.0% | -7.8 pp |
| FY2022 | 67.8% | +22.5 pp |
| FY2021 | 45.4% | -23.9 pp |
| FY2020 | 69.2% | -3.3 pp |
| FY2019 | 72.5% | +29.1 pp |
| FY2018 | 43.4% | +110.1 pp |
| FY2017 | -66.7% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice